CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
CLOVER HEALTH INVESTMENTS, CORP. /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$4.44−0.04 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
Clover Health Investments statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Hospital & Medical Service Plans companies for comparison
Valuation
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Market Cap | $2.36B | $3.25B |
| Enterprise Value | $2.12B | $2.52B |
| PS Ratio | 0.95 | 1.08 |
| PB Ratio | 6.27 | 1.48 |
| P/TBV Ratio | 6.27 | 1.56 |
| P/FCF Ratio | 31.78 | 7.95 |
| P/OCF Ratio | 30.61 | 7.31 |
Enterprise value
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| EV / Sales | 0.86 | 0.93 |
| EV / FCF | 28.56 | 7.33 |
Income (trailing twelve months)
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Revenue | $2.48B | $4.57B |
| Operating Income | -$18.36M | $617.20M |
| Net Income | -$18.36M | $470.80M |
| EBITDA | -$18.33M | $657.96M |
| EPS (Diluted) | -$0.05 | $4.71 |
Margins
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Operating Margin | -0.74% | 4.46% |
| Profit Margin | -0.74% | 10.7% |
| EBITDA Margin | -0.74% | 13.5% |
| FCF Margin | 3.00% | 17.5% |
Returns
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Return on Equity (ROE) | -5.10% | 13.9% |
| Return on Assets (ROA) | -2.84% | 3.31% |
| Return on Invested Capital (ROIC) | -10.3% | 19.7% |
| Return on Capital Employed (ROCE) | -4.62% | 6.00% |
Growth
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 54.0% | 8.06% |
| Revenue Growth (3Y CAGR) | 20.6% | 9.53% |
| Revenue Growth (5Y CAGR) | 23.4% | 8.29% |
Balance sheet
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $238.56M | $482.49M |
| Net Cash (Debt) | $238.56M | $300.85M |
| Net Cash Per Share | $0.45 | $5.27 |
| Equity (Book Value) | $376.26M | $3.63B |
| Book Value Per Share | $0.71 | $41.34 |
| Tangible Book Value | $376.26M | $2.59B |
| Working Capital | $162.12M | $313.96M |
Financial position
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Current Ratio | 1.50 | 1.45 |
| Quick Ratio | 0.74 | 0.98 |
Cash flow (trailing twelve months)
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Operating Cash Flow | $77.03M | $631.50M |
| Capital Expenditures | -$2.83M | -$11.90M |
| Free Cash Flow | $74.21M | $661.55M |
| FCF Per Share | $0.14 | $8.91 |
Efficiency
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Asset Turnover | 3.82 | 0.27 |
| Revenue Per Employee | $3.42M | $1.73M |
| Profits Per Employee | -$25.36K | $208.67K |
| Employee Count | 724 | 1,341 |
Dividends and yields
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Earnings Yield | -0.78% | 9.51% |
| FCF Yield | 3.15% | 12.5% |
| Buyback Yield | 0.00% | 2.89% |
| Shareholder Yield | 0.00% | 4.63% |
Shares
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Shares Outstanding | 531,156,000 | 65,596,200 |
| Shares Change (YoY) | 5.88% | -1.19% |
| Float | 406,583,000 | 56,719,400 |
| Shares Held by Insiders | 23.5% | 3.34% |
| Shares Held by Institutions | 27.5% | 85.3% |
Scores
| Measure | Clover Health Investments | Industry median |
|---|---|---|
| Altman Z-Score | 3.40 | 0.87 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Clover Health Investments's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.